DoW Multiple Sclerosis Investigator-Initiated Research Award
About
Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, high-impact research projects that have the potential to make an important contribution to Multiple Sclerosis (MS) research, patient care, and/or quality of life. All applications must address at least one of the FY26 MSRP IIRA focus areas. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, clinical trial results, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to MS and the proposed research project. Distinctive Features: This funding mechanism includes two options: Established Investigator or New Investigator. The New Investigator option supports applicants early in their faculty appointments.
The DoW Multiple Sclerosis Investigator-Initiated Research Award (IIRA) is a competitive research funding opportunity designed for scientists and clinicians conducting groundbreaking multiple sclerosis research. This program supports rigorous, high-impact research projects that advance MS science, improve patient care, and enhance quality of life for those affected by the disease. Researchers at any career stage can apply through two distinct pathways: the Established Investigator option for experienced researchers, and the New Investigator option specifically designed to support early-career faculty members launching independent research programs. The award accepts research across all phases except clinical trials, making it ideal for laboratory-based discovery, translational research, and population-based studies. All applications must address at least one of the FY26 MSRP IIRA focus areas and include preliminary or published data demonstrating feasibility. Whether your research originates from laboratory breakthroughs, clinical observations, or evidence-based insights, this program provides the support needed to advance MS research and ultimately benefit patients. Research ideas may be derived from laboratory discovery, clinical trial results, population studies, clinician expertise, or preliminary data. This is an excellent opportunity for MS researchers seeking substantial federal funding to advance their investigations.
Funding Facts
● Applications openDeadline
August 13, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle
Deadline
2026-08-13
Grant Type
federal
Application Cycle
Annual
Best For
MS researchers, early-career faculty, established investigators conducting rigorous MS research
Frequently Asked Questions
Who is eligible for DoW Multiple Sclerosis Investigator-Initiated Research Award?
The program offers two eligibility tracks: Established Investigator and New Investigator options. The New Investigator track specifically supports applicants early in their faculty appointments. For complete eligibility requirements, including institutional affiliations, citizenship status, and specific qualifications, please visit the official program website.
How much funding does DoW Multiple Sclerosis Investigator-Initiated Research Award provide?
The specific funding amount is not publicly listed and may vary by fiscal year and research focus area. For current funding ranges and budget information for FY26, please consult the official Department of Defense Multiple Sclerosis Research Program website.
How do I apply for DoW Multiple Sclerosis Investigator-Initiated Research Award?
Applications are submitted through the official Department of Defense grant portal. All proposals must address at least one FY26 MSRP IIRA focus area and include preliminary and/or published data relevant to MS research. The application deadline is August 13, 2026. Prospective applicants should review detailed instructions and submission requirements on the official website before beginning the application process.
What can DoW Multiple Sclerosis Investigator-Initiated Research Award funding be used for?
Funding supports rigorous research projects that advance Multiple Sclerosis science and patient care. This includes laboratory discovery, translational research, and population-based studies. Research may be informed by clinical observations, laboratory findings, or preliminary data. Clinical trials are excluded from this funding mechanism. Contact the program directly to confirm whether your specific research activities qualify.
Last updated: July 5, 2026